Note: Mounjaro , Victoza , Rybelsus , and Ozempic are not FDA-approved to treat obesity or for weight loss
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in the management of type 2 diabetes mellitus (T2DM) due to their dual effects on glycemic control and body weight
When taking regular medications, having a chronic condition, or simply being unsure, its always better to check with your doctor before starting
Securing marketing approval also requires the submission of information about the product manufacturing process to, and inspection of manufacturing facilities by, the FDA, EMA, and other comparable foreign regulatory authorities
-
These symptoms can lead to dehydration and electrolyte disturbances, which may contribute to feelings of light-headedness or faintness